Pharma Reviews: M&A deals in pharma sector decline in 2017 amid tough business conditions

Pricing pressure and regulatory interventions in key markets of India and the US have resulted in a decline in number of pharma M&A deals.
Read more: M&A deals in pharma sector decline in 2017 amid tough business conditions